- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
- Paralegals
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 28, 2023Robins Kaplan Ranks in Top 10% For Pro Bono By Law360
-
September 25, 2023Jake Holdreith Admitted to American College of Trial Lawyers
-
September 22, 2023Robins Kaplan Attorneys Named 2023 New York Super Lawyers and Rising Stars
-
October 4, 2023Lying, Cheating, and Stealing Seminar 2023
-
October 27, 2023LGBTQ Legal Services: Transgender Name Change Clinic
-
October 26-27, 2023MAJ 2023 New Lawyer Bootcamp
-
September 2023Evenstad Family Trial Aftermath: Rule 408 May Not Be Used as a Sword and Shield
-
September 2023Meet Our Keynote Speaker: Journalist and New York Times Contributor Katie Engelhart
-
September 2023Walking the Razor’s Edge: Client Capacity and the Attorney-Client Relationship
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Holly H. Dolejsi
Holly H. Dolejsi
Partner
Pronouns: she/her
Experience
Since joining Robins Kaplan, Holly Dolejsi has been heavily involved in some of the most notable cases handled by firm’s Mass Tort group. Most often, she represents individuals harmed by medical devices or pharmaceuticals. A key to her effective advocacy is that she never lets the size of the case keep her from remembering the individual. Always foremost in her mind, each and every client benefits from her compassion, dedication, and legal skills. She listens, she empathizes, and uses her considerable talents to bring relief.
Her peers recognize her outstanding skills as well, often referring clients to her and choosing her to serve in major roles in big cases involving serious issues. Most often, she represents individuals harmed by medical devices or pharmaceuticals. She is also handling cases on behalf of dozens of Native American tribes for damages caused by the opioid epidemic, as well as the State of Minnesota in its case against JUUL for damages caused by the youth vaping epidemic in Minnesota.
These matters are complex, often high-profile cases that tread new ground. They demand an intelligent, focused, organized attorney driven by the desire to learn and grow. Holly brings those talents to Robins every day, along with empathy for the individuals involved and a passion to bring them relief.
State of Minnesota v. Juul Labs, Inc. et al., Case No. 27-CV-19-19888: Represented the State of Minnesota in litigation against e-cigarette manufacturer JUUL and Altria for deceptively marketing tobacco products and targeting Minnesota’s youth. After a three-week trial, JUUL and Altria were ordered to pay a total of $60.5 million to the State of Minnesota over an eight-year period. This settlement is the largest per capita of all 48 states and territories that have settled with JUUL.
In Re: National Prescription Opiate Litigation, MDL No. 2804, Case No. 17-md-02804: Represented 28 Tribal Nations asserting that the manufacturers of prescription opioids grossly misrepresented the risks of long-term use of those drugs for persons with chronic pain, and distributors failed to properly monitor suspicious orders of those prescription drugs, all of which contributed to the current opioid epidemic. Robins Kaplan obtained a historic first in Tribal Government litigation, with a total of $1.5 billion in settlements obtained on behalf of the Tribal Nations.
In re Farxiga (Dapagliflozin) Products Liability Litigation, MDL No. 2776: Appointed Co-Lead Counsel of the Farxiga Multidistrict Litigation. Farxiga is diabetes drugs which Plaintiffs allege caused ketoacidosis. This woman-run MDL resolved in just under three years.
Benicar Multi-District Litigation, MDL No. 2606 (D.N.J.): Represented clients in, and served on the Bellwether Committee of, the Benicar (Olmesartan) Multi-District Litigation. The MDL reached a global $358 million settlement.
In Re: Invokana (Canagliflozin) Product Liability Litigation, MDL No. 2750: Served on the Plaintiffs’ Steering Committee of the Invokana Multi-District litigation.
Stryker Rejuvenate and ABG II Hip Step New Jersey Multi-County Litigation, MCL 296: Represented clients in the New Jersey Multi-County Stryker Rejuvenate and ABG II Modular Hip Stem litigation, including two Plaintiffs who resolved their cases through the NJ Court’s bellwether mediation program. Assisted in developing a global settlement program for both the multi-county litigation and the federal multi-district litigation, a program valued at over $1 billion.
- Named a "Minnesota Super Lawyer," Super Lawyers (2023)
- Listed in "500 Leading Plaintiff Consumer Lawyers" List, Lawdragon (2023)
- Named an "Attorney of the Year," Minnesota Lawyer (2022)
- Named a “North Star Lawyer” by the Minnesota State Bar Association for providing at least 50 hours of pro bono legal services (2022)
- Legal Council on Legal Diversity Fellow (2021)
- Recipient of Minnesota Lawyer's Diversity and Inclusion Award (2020)
- Named a “Member of the Year,” Minnesota Association for Justice (2018)
- Named an "Up & Coming Attorney," Minnesota Lawyer (2017)
- Named to the "Top 40 Under 40" list, The National Trial Lawyers (2015)
- Named a "Minnesota Rising Star," Super Lawyers (2015-2019)
- CALI Award for Torts I and Assisted Reproductive Technology and the Law (2009)
- Trustee Merit Scholarship (2006-2009)
- Minnesota
- U.S. District Court, Central District of Illinois
- U.S. District Court, Minnesota
- William Mitchell College of Law, J.D., magna cum laude (2009)
- Northwestern University, B.A. in Anthropology (2003)
- American Bar Association
- Federal Bar Association
- Law360 Product Liability Editorial Advisory Board (2022-2023)
- Federal Bar Association
- Minnesota State Bar Association
- Minnesota Association for Justice
- American Association for Justice
- Public Justice
- The American Lawyer, Young Lawyer Editorial Board
- "Law360 2023 Product Liability Editorial Board," Law360 (August 7, 2023)
- "Will Bankruptcy Judge Bend On Halting Talc Cases Against J&J? Juul Settles AG Cases But SF Trial Looms," ALM Litigation: Editor's Picks (April 19, 2023)
- "2022 Attorneys of the Year: National Prescription Opiate Litigation," Minnesota Lawyer (February 16, 2023)
- "For some transgender people, a legal name change is a big step forward," MPR News (December 15, 2022)
- "Robins Kaplan on the Front Lines of $589M National Opioid Settlement on Behalf of Tribal Nations, Attorney at Law Magazine (March 2022)
- "Taking a Stand for Justice," profiled in Attorney at Law Magazine's 2020 Next Generation Attorney Series (May 2020)
- Learning from Your Mistakes to Avoid Ethical Quandaries
MAJ New Lawyer Bootcamp, Minneapolis, Minnesota (November 11, 2022)
- The Drug and Device Business: Navigating Consumer Claims Against the Makers of Harmful Prescription Drugs and Medical Devices, Hennepin County Bar Association, Minneapolis, Minnesota (November 21, 2017)
- Developing Your Litigation Style: Straddling Effectiveness and Gender Stereotypes
Women Trial Lawyer Conference (November 3, 2017) - How to Make Lasting Change in Your Firm’s Culture
Minnesota Lawyer Diversity & Inclusion Awards CLE, Minneapolis, Minnesota (October 5, 2022) - Drugs and Devices: What You Don’t Know Can Hurt You
Minnesota Association for Justice, Annual Conference (August 19, 2017) - Advising Your Clients on Mass Tort Settlements
The American Association for Justice, Annual Conference (July 24, 2017) - Depositions and Discovery
Minnesota Association for Justice – New Lawyer Boot Camp, Minneapolis, Minnesota (May 10, 2017) - Overview of SGLT2 Inhibitors and the Defendants
American Association for Justice, Los Angeles, California (July 23, 2016) - Benicar The Bellwether Process
AAJ Benicar Litigation Group, Boca Raton, Florida (February 27, 2016) - SGLT2 Inhibitor Litigation
Moderator, American Association for Justice, Webinar (August 20, 2015) - Case Criteria and Review
American Association for Justice, Montreal, Canada (July 12, 2015) - Ineligible Cases What To Do With Your Unsettled Cases
American Association for Justice, Montreal, Canada (July 11, 2015) - Benicar Litigation Group Meeting
The American Association For Justice Annual Convention, Desert Springs, California (February 24, 2015) - Stryker Rejuvenate and ABG II Modular Hip Stem Litigation Updates
The American Association for Justice Annual Convention, Baltimore, Maryland (August 19, 2014) - Mass Tort Update
Minnesota Association for Justice Annual Convention, Alexandria, Minnesota (August 19, 2014) - The “ABC’s of Mass Torts”
Minnesota Association for Justice Annual Convention, Alexandria, MN (August 14, 2014)
RESOURCES
PUBLICATIONS
NEWS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.